Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/337"

Predicate	Value (sorted: none)
rdf:type	?:Evidence
rdf:type	?:Item
rdfs:label	"evidence_1360"
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:Evidence_dose	"0.6"
?:Evidence_enzyme_system	""
?:Evidence_value	"0.000466"
dc:creator	"boycer"
dc:date	"09/24/2009 14:57:05"
?:content	"During oral administration of 200 mg or 300 mg twice daily for 14 days in patients at risk of aspergillosis (mainly patients with malignant neoplasms of lymphatic or hematopoietic tissue), the observed pharmacokinetic characteristics were similar to those observed in healthy subjects: Cmax @ 200 mg Oral Q12h(n=9): 3.0mcg/mL Cmax @ 300 mg Oral Q12h(n=9): 4.66mcg/mL 3mcg/mL X 1g/10^6mcg X 1000mL/1L = 0.0003g/L 4.66mcG/mL X 1g/10^6mcg X 1000mL/1L = 0.000466g/L"
rdfs:seeAlso	?:ce3ef5cf-3087-4d92-9d94-9eb8287228db

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ voriconazole_maximum_concentration_continuous_value, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1360 }

Context graph